HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008.

Abstract
The aim of this study was to characterize the adverse events of attenuated measles vaccine in mainland China. We carried out prospective follow-up of adverse events after mass measles immunization practices, categorizing them into two groups: allergic reactions and serious adverse events. The incidence of anaphylaxis reaction was estimated to be 6.5 per million for attenuated measles vaccine. Among 14.3 million vaccination practices, 1 case each of acute disseminated encephalomyelitis (ADEM) and idiopathic thrombocytopenic purpura (ITP) and 28 cases of Henoch-Schonlein purpura (HSP) were reported. The total incidence of serious adverse events after vaccination was 2.14 per million doses.
AuthorsMin Shu, Qinglian Liu, Jin Wang, Rui Ao, Chaomei Yang, Gang Fang, Chaomin Wan, Wenjun Guo
JournalVaccine (Vaccine) Vol. 29 Issue 18 Pg. 3507-10 (Apr 18 2011) ISSN: 1873-2518 [Electronic] Netherlands
PMID19909830 (Publication Type: Journal Article)
CopyrightCopyright © 2009 Elsevier Ltd. All rights reserved.
Chemical References
  • Measles Vaccine
  • Vaccines, Attenuated
Topics
  • Adolescent
  • Anaphylaxis (chemically induced)
  • Child
  • Child, Preschool
  • China
  • Female
  • Follow-Up Studies
  • Humans
  • IgA Vasculitis (chemically induced)
  • Incidence
  • Infant
  • Male
  • Mass Vaccination
  • Measles Vaccine (adverse effects)
  • Urticaria (chemically induced)
  • Vaccines, Attenuated (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: